Many therapeutic molecules used in cancer treatments are highly toxic, often harming healthy tissues and causing significant ...

Novo Nordisk A/S still looks like a buy: oral Wegovy growth, solid global demand, 13x forward P/E, and buybacks support upside. Click for this NVO stock update.

We just don’t know what the patient is getting when they get it from a compounder,” she said. “We don’t know how effective it’s going to be. It may have other ...

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss ...

Some experts recommend smoking rather than injecting fentanyl to avoid needle-related diseases. But, smoking fentanyl is dangerous and can lead to second and third-hand exposures.

Researchers at Scripps Research have redesigned fentanyl at the molecular level, challenging decades-old assumptions about opioid chemistry.

GLP-1 weight-loss drugs are now the focus of a heated legal battle, with a leading drugmaker warning that copycat versions pose a risk to patient safety. "When you go and try to source raw materials ...

Hims & Hers has withdrawn its $49 compounded semaglutide pill after pressure from top U.S. health officials at the FDA and HHS. The company now faces a lawsuit from Novo Nordisk for patent ...

Giorgia Guglielmi is a freelance writer in Basel, Switzerland. In 2021, amid the COVID‑19 pandemic, Kristin Wall became pregnant with her second child. Her physician told her that little was known ...

FDA labeling now recommends DPYD variant testing before initiating capecitabine or 5-FU, except when immediate treatment is clinically necessary. Complete DPD deficiency markedly impairs 5-FU ...